CISO Global, Inc. CISO
Nasdaq · XNAS · stock · Services-Management Consulting Services
Chart by TradingView
5/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $26.6M | $30.8M | $33.9M | $46.5M | $15.1M |
| Gross profit | $6.8M | $4.5M | $2.6M | $2.7M | $1.8M |
| Operating income | -$8.8M | -$14.6M | -$63.0M | -$33.1M | -$39.8M |
| Net income | -$8.1M | -$24.2M | -$80.2M | -$33.8M | -$39.1M |
| Operating cash flow | -$8.0M | -$3.8M | -$5.9M | -$10.7M | -$7.4M |
| Free cash flow | -$8.0M | -$3.9M | -$6.1M | -$11.2M | — |
| Total assets | $25.0M | $26.7M | $51.7M | $104.5M | $35.8M |
| Total liabilities | $8.0M | $25.5M | $35.5M | $28.1M | $10.5M |
| Shareholders' equity | $14.8M | $1.1M | $16.1M | $76.4M | $25.3M |
| Ratios | |||||
| Gross margin | 25.6% | 14.7% | 7.6% | 5.9% | 11.9% |
| Operating margin | -33.0% | -47.4% | -185.5% | -71.2% | -262.7% |
| Net margin | -30.3% | -78.8% | -236.4% | -72.6% | -258.5% |
| FCF margin | -30.0% | -12.8% | -18.1% | -24.0% | — |
| Return on assets | -32.3% | -91.0% | -155.3% | -32.3% | -109.3% |
| Return on equity | -54.5% | -2109.9% | -497.1% | -44.2% | -154.7% |
| Debt / equity | 0.00× | 10.20× | 0.84× | — | 0.17× |
| Current ratio | 0.42 | 0.14 | 0.88 | 0.62 | 1.91 |
| Revenue growth | -13.5% | -9.4% | -27.1% | 207.4% | 109.1% |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001777319 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.